The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells ; volume:4 ; number:1 ; day:22 ; month:12 ; year:2009 ; pages:1-10 ; date:12.2009
Radiation oncology ; 4, Heft 1 (22.12.2009), 1-10, 12.2009
- Creator
-
Welsh, James W.
- Contributor
-
Mahadevan, Daruka
Ellsworth, Ron
Cooke, Laurence
Bearss, David
Stea, Baldassarre
SpringerLink (Online service)
- DOI
-
10.1186/1748-717X-4-69
- URN
-
urn:nbn:de:1111-2016072612291
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Welsh, James W.
- Mahadevan, Daruka
- Ellsworth, Ron
- Cooke, Laurence
- Bearss, David
- Stea, Baldassarre
- SpringerLink (Online service)
Other Objects (12)
Significance of c-MET tyrosine kinase domain mutations T1275I and P1300S
Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities
Correction: Thrombin receptor PAR4 cross-activates the tyrosine kinase c-met in atrial cardiomyocytes
c-Met inhibitors
Resistance to tyrosine kinase inhibitors promotes renal cancer progression through MCPIP1 tumor-suppressor downregulation and c-Met activation
Nucleic acid aptamers against the receptor tyrosine kinases C-Met and EGFR : isolation and biochemical characterization
Tyrosine kinase signaling-independent MET-targeting with CAR-T cells
Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer
Constitutively active c-Met kinase in PC-3 cells is autocrine-independent and can be blocked by the Met kinase inhibitor BMS-777607
Genstatus von PTEN und c-Met in Speicheldrüsenkarzinomen
Genstatus von PTEN und c-Met in Speicheldrüsenkarzinomen
In vitro effectiveness of CB469, a MET tyrosine kinase inhibitor in MET-activated cancer cells
Significance of c-MET tyrosine kinase domain mutations T1275I and P1300S
Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities
Correction: Thrombin receptor PAR4 cross-activates the tyrosine kinase c-met in atrial cardiomyocytes
c-Met inhibitors
Resistance to tyrosine kinase inhibitors promotes renal cancer progression through MCPIP1 tumor-suppressor downregulation and c-Met activation
Nucleic acid aptamers against the receptor tyrosine kinases C-Met and EGFR : isolation and biochemical characterization
Tyrosine kinase signaling-independent MET-targeting with CAR-T cells
Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer
Constitutively active c-Met kinase in PC-3 cells is autocrine-independent and can be blocked by the Met kinase inhibitor BMS-777607
Genstatus von PTEN und c-Met in Speicheldrüsenkarzinomen
Genstatus von PTEN und c-Met in Speicheldrüsenkarzinomen
In vitro effectiveness of CB469, a MET tyrosine kinase inhibitor in MET-activated cancer cells
Significance of c-MET tyrosine kinase domain mutations T1275I and P1300S
Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities
Correction: Thrombin receptor PAR4 cross-activates the tyrosine kinase c-met in atrial cardiomyocytes
c-Met inhibitors
Resistance to tyrosine kinase inhibitors promotes renal cancer progression through MCPIP1 tumor-suppressor downregulation and c-Met activation
Nucleic acid aptamers against the receptor tyrosine kinases C-Met and EGFR : isolation and biochemical characterization
Tyrosine kinase signaling-independent MET-targeting with CAR-T cells
Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer
Constitutively active c-Met kinase in PC-3 cells is autocrine-independent and can be blocked by the Met kinase inhibitor BMS-777607
Genstatus von PTEN und c-Met in Speicheldrüsenkarzinomen
Genstatus von PTEN und c-Met in Speicheldrüsenkarzinomen